(Q41969327)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

title

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

author name string

D L Morton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

L J Foshag

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

J A Nizze

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

E Famatiga

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

L A Wanek

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

C Chang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

D G Davtyan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

R K Gupta

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

R Elashoff

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

language of work or name

English

0 references

publication date

1 October 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

216

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

463-482

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1417196%20AND%20SRC:MED&resulttype=core&format=json

Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients

15 September 2019

cites work

1 reference

12 December 2020

Prognostic significance of cutaneous anergy for the surgical treatment of solid neoplasms

1 reference

12 December 2020

Preliminary results of a randomized trial of adjuvant immunotherapy in patients with malignant melanoma who have lymph node metastases

1 reference

12 December 2020

Cis-dichlorodiammineplatinum(II) alone and combined with DTIC for treatment of disseminated malignant melanoma

1 reference

12 December 2020

Immunochemical characterization of fetal antigen isolated from spent medium of a human melanoma cell line

1 reference

12 December 2020

Ganglioside GM2 as a human tumor antigen (OFA-I-1)

1 reference

12 December 2020

Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists

1 reference

12 December 2020

A monoclonal antibody recognizes an O-acylated sialic acid in a human melanoma-associated ganglioside

1 reference

12 December 2020

Prostaglandins and the immune response to cancer (review).

1 reference

12 December 2020

Primary but not metastatic human melanomas expressing dr antigens stimulate autologous lymphocytes

1 reference

12 December 2020

Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2

1 reference

12 December 2020

Studies of a melanoma tumor-associated antigen detected in the spent culture medium of a human melanoma cell line by allogeneic antibody. I. Purification and development of a radioimmunoassay

1 reference

12 December 2020

HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes

1 reference

12 December 2020

A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III)

1 reference

12 December 2020

Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen

1 reference

12 December 2020

Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture

1 reference

12 December 2020

Immunological factors which influence response to immunotherapy in malignant melanoma.

1 reference

12 December 2020

Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion

1 reference

12 December 2020

Rejection of dinitrochlorobenzene-conjugated syngeneic tumor cells by dinitrochlorobenzene-sensitized guinea pigs.

1 reference

12 December 2020

Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A

1 reference

12 December 2020

Modulation of histamine type II receptors on CD8+ T cells by interleukin-2 and cimetidine

1 reference

12 December 2020

Induction of CD4+ cytotoxic T cells by sensitization with allogeneic melanomas bearing shared or cross-reactive HLA-A

1 reference

12 December 2020

Role of Gangliosides in Active Immunotherapy with Melanoma Vaccine

1 reference

12 December 2020

Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor

1 reference

12 December 2020

Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas

1 reference

12 December 2020

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

12 December 2020

Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases

1 reference

12 December 2020

Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamide

1 reference

12 December 2020

Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon alpha in a murine hepatic metastasis model

1 reference

12 December 2020

An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy

1 reference

12 December 2020

Active specific immunotherapy in malignant melanoma

1 reference

12 December 2020

Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma

1 reference

12 December 2020

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

12 December 2020

Electrocardiogram studies on cancer patients treated with OK-432, a streptococcal preparation with potent biological response modifier activities

1 reference

12 December 2020

Induction of antibodies to a tumor-associated antigen by immunization with a whole melanoma cell vaccine

1 reference

12 December 2020

Inhibition of suppressor-cell activity by cyclophosphamide in patients with malignant melanoma

1 reference

12 December 2020

Modulation of suppressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia

1 reference

12 December 2020

Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide

1 reference

12 December 2020

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Immunogenicity of a polyvalent melanoma antigen vaccine in humans

1 reference

12 December 2020

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

1 reference

12 December 2020

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

1 reference

12 December 2020

Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans

1 reference

12 December 2020

Combination tumor-immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice.

1 reference

12 December 2020

Active immunotherapy against cancer: present status.

1 reference

12 December 2020

Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide

1 reference

12 December 2020

Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.

1 reference

12 December 2020

A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates

1 reference

12 December 2020

Clinical-biologic patterns of metastatic melanoma and their effect on treatment

1 reference

12 December 2020

Demonstration of antibodies against human malignant melanoma by immunofluorescence.

1 reference

12 December 2020

BCG immunotherapy of malignant melanoma: summary of a seven-year experience

1 reference

12 December 2020

Surgical Resection and Adjunctive lmmunotherapy for Selected Patients with Multiple Pulmonary Metastases

1 reference

12 December 2020

Complications of BCG immunotherapy in patients with cancer

1 reference

12 December 2020